Shaping the Future of Nuclear Medicine at NCNM 2026

https://www.linkedin.com/posts/medi-radio-malaysia_shaping-the-future-of-nuclear-medicine-at-activity-7506221954408816641-2XN2?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFuKB-ABVoOzvJt090x_djmAVpdvsYJpXz4

We are thrilled to announce that Medi Radio Malaysia Sdn Bhd (MRM) is officially sponsoring and participating in the upcoming National Conference of Nuclear Medicine (NCNM) 2026!

As a premier centralized radiopharmacy dedicated to improving clinical outcomes, we look forward to connecting with leading clinicians, researchers, physicists, and radiopharmacists to drive next-generation advancements in molecular imaging and therapy.

📍 Venue: Raia Hotel & Convention Centre, Kuching, Sarawak

📅 Dates: 17–19 September 2026

What We are Bringing to NCNM 2026

Stop by our space (Booth 9) to explore our comprehensive portfolio designed to optimize molecular imaging and precision cancer care:

Theranostics: High-impact radioisotopes driving the future of targeted radionuclide therapy, including Lu177, Ac225, Tb161

Conventional Nuclear Medicine: A reliable, robust supply chain for critical diagnostic and therapeutic staples like Tc99m and I131 (solution and capsules).

Cold Kits & Radiochemicals: High-quality APIs and formulation kits including PSMA, Dotatate, LM3, and FAPI.

Filtration System: Our innovative "Hot Toilet" filtration solution that safely eliminates up to 99.995% of radionuclides, expanding hospital treatment capacities without complex infrastructure investments.

Let's collaborate to elevate patient care and radiopharmaceutical innovation across Asia. See you in Kuching!